Repositioning Candidates

Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3

Search for:

     Bone
137 records.
Candidate ID Source ID Source Type Compound Type Candidate Name Inclusion Criteria
R1322 DB10770 approved biotech Foreskin fibroblast (neonatal) Target associated Details
R1323 DB10771 approved biotech Bovine type I collagen Indication associated Details
R1324 DB10772 approved biotech Foreskin keratinocyte (neonatal) Target associated Details
R1355 DB11239 approved small molecule Aluminum sulfate Therapeutic strategy associated Details
R1356 DB11242 approved; vet_approved small molecule Gelatin Indication associated Details
R1375 DB11569 approved; investigational biotech Ixekizumab Therapeutic strategy associated Details
R1389 DB11660 approved; investigational small molecule Latanoprostene bunod Indication associated Details
R1408 DB11817 approved; investigational small molecule Baricitinib Therapeutic strategy associated Details
R1416 DB11866 approved; investigational biotech Romosozumab Indication associated Details
R1417 DB11921 approved; investigational small molecule Deflazacort Therapeutic strategy associated Details
R1418 DB11928 approved; investigational biotech Vosoritide Therapeutic strategy associated Details
R1422 DB11952 approved; investigational small molecule Duvelisib Therapeutic strategy associated Details
R1427 DB12007 experimental small molecule Isoflavone Therapeutic strategy associated Details
R1428 DB12010 approved; investigational small molecule Fostamatinib Target associated Details
R1429 DB12023 approved; investigational biotech Benralizumab Therapeutic strategy associated Details
R1441 DB12281 approved; investigational biotech Luspatercept Therapeutic strategy associated Details
R1449 DB12483 approved; investigational small molecule Copanlisib Therapeutic strategy associated Details
R1474 DB13142 approved small molecule Calcium glubionate anhydrous Indication associated Details
R1485 DB13174 experimental small molecule Rhein Therapeutic strategy associated Details
R1492 DB13615 approved; experimental small molecule Mifamurtide Therapeutic strategy associated Details
R1493 DB13749 approved; investigational small molecule Magnesium gluconate Indication associated Details
R1496 DB13854 approved; investigational small molecule Gamolenic acid Therapeutic strategy associated Details
R1499 DB13906 experimental biotech Aloe vera leaf Therapeutic strategy associated Details
R1505 DB13949 approved small molecule Ferric cation Therapeutic strategy associated Details
R1506 DB13973 approved; investigational biotech Remestemcel-L Therapeutic strategy associated Details
R1515 DB14012 approved; investigational biotech Burosumab Indication associated Details
R1517 DB14059 experimental; investigational small molecule SC-236 Therapeutic strategy associated Details
R1523 DB14513 approved; experimental; investigational small molecule Magnesium Indication associated Details
R1540 DB14731 approved; investigational biotech Tagraxofusp Therapeutic strategy associated Details
R1544 DB14811 approved; investigational biotech Isatuximab Therapeutic strategy associated Details
R1555 DB15091 approved; investigational small molecule Upadacitinib Therapeutic strategy associated Details
R1566 DB15595 approved biotech Ebola Zaire vaccine (live, attenuated) Therapeutic strategy associated Details
R1573 DB15726 investigational biotech Human Umbilical Cord Mesenchymal Stem Cells Therapeutic strategy associated Details
R1574 DB15729 investigational biotech Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Therapeutic strategy associated Details
R1576 DB15731 investigational biotech Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells Therapeutic strategy associated Details
R1577 DB15742 investigational biotech MultiStem Therapeutic strategy associated Details
R1601 DB16620 investigational small molecule Methopterin Therapeutic strategy associated Details